Journey Medical Corporation (DERM) financial statements and ratios from SEC XBRL: revenue $61.86M (TTM), net margin -18.5%, revenue growth 23.3% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $61.86M |
| Net Margin | -18.5% |
| Revenue Growth (YoY) | 23.3% |
| EPS Growth (YoY) | -93.8% |
| Price / Book | 6.64 |
| Price / Sales | 3.13 |
| Altman Z-Score | 1.10 (distress) |
| Piotroski F-Score | 4/9 |
| Sector P/E (Healthcare) | 21.7 |
DERM overview · DERM earnings · DERM KPIs · DERM investor relations · DERM ownership · DERM peers · DERM filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.